Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 21.16 Million USD | -36.79% |
| 2022 | 33.49 Million USD | -26.41% |
| 2021 | 45.5 Million USD | 32.84% |
| 2020 | 34.25 Million USD | -13.58% |
| 2019 | 39.64 Million USD | 646.69% |
| 2018 | 5.3 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 5.9 Million USD | -7.28% |
| 2023 Q1 | 6.36 Million USD | -0.2% |
| 2023 Q3 | 5.02 Million USD | -14.78% |
| 2023 Q4 | 4.33 Million USD | -13.8% |
| 2023 FY | 21.16 Million USD | -36.79% |
| 2022 Q4 | 6.37 Million USD | -4.89% |
| 2022 Q3 | 6.7 Million USD | -14.36% |
| 2022 FY | 33.49 Million USD | -26.41% |
| 2022 Q2 | 7.82 Million USD | -21.1% |
| 2022 Q1 | 9.92 Million USD | -12.6% |
| 2021 FY | 45.5 Million USD | 32.84% |
| 2021 Q4 | 11.35 Million USD | -7.09% |
| 2021 Q3 | 12.21 Million USD | 2.36% |
| 2021 Q2 | 11.93 Million USD | 19.38% |
| 2021 Q1 | 9.99 Million USD | 4.26% |
| 2020 Q4 | 9.59 Million USD | 41.36% |
| 2020 Q3 | 6.78 Million USD | -17.59% |
| 2020 Q2 | 8.23 Million USD | -14.72% |
| 2020 Q1 | 9.65 Million USD | -49.44% |
| 2020 FY | 34.25 Million USD | -13.58% |
| 2019 Q1 | 6.37 Million USD | 0.0% |
| 2019 FY | 39.64 Million USD | 646.69% |
| 2019 Q3 | 12.68 Million USD | 53.75% |
| 2019 Q4 | 19.09 Million USD | 50.58% |
| 2019 Q2 | 8.24 Million USD | 29.32% |
| 2018 FY | 5.3 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -156.505% |
| BioQuest Corp. | 89.76 USD | -23583901.783% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | 84.956% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -117.546% |
| GSRX Industries Inc. | - USD | -Infinity% |
| High Sierra Technologies, Inc. | 238.36 Thousand USD | -8780.955% |
| Instadose Pharma Corp. | - USD | -Infinity% |